Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.

Hochhaus A, O'Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L, Goldman JM, Müller MC, Radich JP, Rudoltz M, Mone M, Gathmann I, Hughes TP, Larson RA. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. 2009 Jun; 23(6):1054-61.

View in: PubMed

collapse authors with profiles